Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies

Clinical trial NCT01760226 · COMPLETED

Trial details

NCT number: NCT01760226
Sponsor: Baylor College of Medicine
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma Post Transplant Lymphoproliferative Disorder Primary Mediastinal (Thymic) Large B-cell Lymphoma

Start date: 2013-01-01
Primary completion: 2016-08-26
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.